This inventor holds 2 USPTO granted patents. Top assignee: Nestec S.a.. Active years: 1994-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1996
Title: Beatrice Vagneur: Innovator in Pharmaceutical Delivery Systems
Introduction
Beatrice Vagneur is a notable inventor based in Angers, France. She has made significant contributions to the field of pharmaceutical compositions, particularly in the development of innovative delivery systems. With a total of 2 patents to her name, her work is recognized for its potential impact on therapeutic applications.
Latest Patents
Vagneur's latest patents include a pharmaceutical composition in gel form within a dispensing package. This innovative delivery system features a dispenser pack that contains a pharmaceutical composition, which includes a pharmaceutical active principle homogeneously distributed in a water-dispersible gel excipient. The gel is formulated with an acrylamide or acrylamidine gelling agent. Another patent focuses on a pharmaceutical active principle delivery system that contains the active principle in either solution or solid form within an excipient gel. This gel is designed to be pseudoplastic and thixotropic, allowing for effective therapeutic dosing through a metering pump.
Career Highlights
Beatrice Vagneur is currently associated with Nestec S.A., where she continues to advance her research and development efforts in pharmaceutical technologies. Her work is characterized by a commitment to improving drug delivery methods, which can enhance patient outcomes.
Collaborations
Throughout her career, Vagneur has collaborated with esteemed colleagues such as Pierre Tachon and Jean-Louis Viret. These partnerships have contributed to her innovative approaches and the successful development of her patents.
Conclusion
Beatrice Vagneur stands out as a pioneering inventor in the pharmaceutical industry, with her patents reflecting a dedication to enhancing drug delivery systems. Her contributions are poised to make a lasting impact on therapeutic practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
